ZitkusBS.Update on the American Diabetes Association standards of medical care. Nurse Pract, 2014; 39: 22–32; quiz 32–3.
2.
KirkmanMS, BriscoeVJ, ClarkN, et al.Diabetes in older adults. Diabetes Care, 2012; 35: 2650–2664
3.
CukiermanT, GersteinHC, WilliamsonJD. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia, 2005; 48: 2460–2469.
4.
BiesselsGJ, DearyIJ, RyanCM. Cognition and diabetes: a lifespan perspective. Lancet Neurol, 2008; 7: 184–190.
5.
ReijmerYD, van den BergE, RuisC, et al.Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev, 2010; 26: 507–519.
6.
ExaltoLG, BiesselsGJ, KarterAJ, et al.Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol, 2013; 1: 183–190.
7.
AndersonRJ, FreedlandKE, ClouseRE, et al.The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care, 2001; 24: 1069–1078.
8.
GreggEW, MangioneCM, CauleyJA, et al.Diabetes and incidence of functional disability in older women. Diabetes Care, 2002; 25: 61–67.
9.
WongE, BackholerK, GearonE, et al.Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol, 2013; 1: 106–114.
10.
ParkSW, GoodpasterBH, StrotmeyerES, et al.Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes care, 2007; 30: 1507–1512.
11.
ParkSW, GoodpasterBH, StrotmeyerES, et al.Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes, 2006; 55: 1813–1818.
12.
ParkSW, GoodpasterBH, LeeJS, et al.Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care, 2009; 32: 1993–1997.
13.
VolpatoS, LeveilleSG, BlaumC, et al.Risk factors for falls in older disabled women with diabetes: the women's health and aging study. J Gerontol A Biol Sci Med Sci, 2005; 60: 1539–1545
14.
VolpatoS, BianchiL, LauretaniF, et al.Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care, 2012; 35: 1672–1679.
15.
PunthakeeZ, MillerME, LaunerLJ, et al.Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes care, 2012; 35: 787–793.
16.
SinclairAJ, GirlingAJ, BayerAJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. All Wales Research into Elderly (AWARE) Study. Diabetes Res Clin Pract, 2000; 50: 203–212.
17.
RousselR, RivelineJ-P, VicautE, et al.Important drop rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF Study. Diabetes Care, 2021; 44: 1368–1376.
18.
SinclairAJ, AbdelhafizAH, Rodríguez-MañasLJ. Frailty and sarcopenia—newly emerging and high impact complications of diabetes. J Diabetes Complications, 2017; 31: 1465–1473.
19.
MaG-C, ZouL-L, DaiW, et al.The association between glucose fluctuation with sarcopenia in elderly patients with type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci, 2023; 27: 1912–1920
20.
MunshiMN. Continuous glucose monitoring use in older adults for optimal diabetes management. Diabetes Technol Ther, 2023; 25 (Suppl 3): S56–S64.
21.
McAuleySA, TrawleyS, VogrinS, et al.Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial. Diabetes Care, 2022; 45: 381–390.
22.
HuangES, SinclairA, ConlinPR, et al.The growing role of technology in the care of older adults with diabetes. Diabetes Care, 2023; 46: 1455–1463.
